How Tiny Particles Affect Our Lungs: New Research from nanoPASS

A new study from Helmholtz Munich scientists, Markus Rehberg and Tobias Stoeger, partners in the nanoPASS project, reveals how certain nanoparticles can impact our lungs’ immune response. Published in Advanced Science, the research shows that specific types of nanoparticles—tiny materials used in medicine—can trigger white blood cells to gather in the lungs, potentially leading to inflammation.

These findings are key for designing safer nanoparticles for medical use, like targeted drug delivery to the lungs. Understanding how these particles interact with the body helps researchers make sure they’re safe and effective.

Read more about this important discovery here: https://doi.org/10.1002/advs.202404661.